Johnson & Johnson financial data

Symbol
JNJ on NYSE
Industry
Pharmaceutical Preparations
Location
One Johnson & Johnson Plz, New Brunswick, NJ
State of incorporation
NJ
Fiscal year end
December 29
Former names
JOHNSON & JOHNSON ET AL (to 1/23/1996)
Latest financial report
10-Q - Q3 2024 - Oct 23, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 110 % +1.32%
Quick Ratio 23.6 % +7.38%
Debt-to-equity 149 %
Return On Equity 20.9 % -55.4%
Return On Assets 8.4 % -55%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.41B shares +0.01%
Entity Public Float 430B USD -8.9%
Common Stock, Value, Issued 3.12B USD 0%
Weighted Average Number of Shares Outstanding, Basic 2.41B shares -4.59%
Weighted Average Number of Shares Outstanding, Diluted 2.43B shares -4.78%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 87.7B USD +4.77%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 17.6B USD +25.2%
Income Tax Expense (Benefit) 2.86B USD +99.9%
Net Income (Loss) Attributable to Parent 14.7B USD -57.6%
Earnings Per Share, Basic 6.1 USD/shares -55.2%
Earnings Per Share, Diluted 6.05 USD/shares -55.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 20B USD +1.28%
Marketable Securities, Current 317M USD -91.6%
Cash, Cash Equivalents, and Short-term Investments 20.3B USD -13.7%
Accounts Receivable, after Allowance for Credit Loss, Current 16.2B USD +9.3%
Inventory, Net 12.6B USD +12.5%
Assets, Current 53.2B USD -0.85%
Deferred Income Tax Assets, Net 9.35B USD +0.97%
Property, Plant and Equipment, Net 20.5B USD +8.81%
Operating Lease, Right-of-Use Asset 1B USD -9.09%
Intangible Assets, Net (Excluding Goodwill) 39.5B USD +12.8%
Goodwill 44.8B USD +24%
Other Assets, Noncurrent 10.9B USD -16.8%
Assets 178B USD +7.36%
Accounts Payable, Current 8.95B USD +7.17%
Employee-related Liabilities, Current 3.62B USD +8.48%
Accrued Liabilities, Current 11.5B USD +13.4%
Liabilities, Current 51.8B USD +16.7%
Accrued Income Taxes, Noncurrent 354M USD -86.1%
Deferred Income Tax Liabilities, Net 2.95B USD +12.5%
Other Liabilities, Noncurrent 14.9B USD +10%
Liabilities 108B USD +14%
Accumulated Other Comprehensive Income (Loss), Net of Tax -12.5B USD -42.6%
Retained Earnings (Accumulated Deficit) 155B USD +1.73%
Stockholders' Equity Attributable to Parent 70.2B USD -1.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 70.2B USD -1.5%
Liabilities and Equity 178B USD +7.36%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 3.66B USD +12.3%
Net Cash Provided by (Used in) Financing Activities 546M USD -91.1%
Net Cash Provided by (Used in) Investing Activities -464M USD -114%
Common Stock, Shares Authorized 4.32B shares 0%
Common Stock, Shares, Issued 3.12B shares 0%
Common Stock, Par or Stated Value Per Share 1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.61B USD -71.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 20B USD +1.28%
Operating Lease, Liability 1.1B USD -15.4%
Payments to Acquire Property, Plant, and Equipment 807M USD -6.49%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 1.43B USD -94.5%
Property, Plant and Equipment, Gross 49.3B USD +8%
Deferred Income Tax Expense (Benefit) -1.56B USD -1.23%
Preferred Stock, Shares Authorized 2M shares 0%
Unrecognized Tax Benefits 2.4B USD +4.35%
Amortization of Intangible Assets 4.6B USD +15%
Depreciation, Depletion and Amortization 1.82B USD -3.46%
Deferred Tax Assets, Net of Valuation Allowance 12.7B USD -1.29%
Interest Expense 715M USD +49.6%